Sexual Health Care

• Purpose of This Guideline
• Biomedical Prevention of STIs
• Practical Considerations for Doxy-PEP Implementation
• All Recommendations

• Purpose of This Guideline
• Mpox Prevention
• Mpox Presentation and Diagnosis
• Mpox Treatment
• All Recommendations

• Purpose of This Guidance
• Multifaceted Patient-Centered Sexual Health Care
• Components of a Patient-Centered Approach
• Resources for Care Providers

The GOALS framework streamlines sexual history taking to enhance the patient-clinician relationship and elicit information most useful for identifying an appropriate clinical course of action, such as screening, testing, and education.

Go to resource | Download PDF

• Purpose of This Guidance
• Definition, Legality, and Eligibility
• Treatment, Medications, and Follow-Up
• Patient Education
• Best Practice Reminders

• Purpose of This Guideline
• Clinical Manifestations
• Laboratory Testing and Diagnosis
• Treatment
• All Recommendations

• Purpose of This Guideline
• New York State Law and Testing Requirements
• Time to HIV Detection
• HIV Testing With the Standard 3-Step Algorithm
• Diagnosis of HIV-2 Infection
• Appendix: HIV Immunoassays Available in New York State
• All Recommendations

• Purpose of This Guideline
• Rationale
• Who to Test for HCV Infection
• HCV Testing Sequence and Diagnosis
• All Recommendations

• Purpose of This Guideline
• HPV-Associated Cancers
• HPV Prevention
• Cervical and Anal Cancer Screening
• Presentation and Diagnosis of HPV Infection
• HPV Treatment
• Partner Exposure to HIV and HPV
• All Recommendations

• What is U=U?
• Application to Clinical Practice
• Counseling Individuals About U=U
• Counseling Couples About U=U

Please refer to CDC > Sexually Transmitted Infections Treatment Guidelines, 2021

Note: As of January 31, 2025, this resource may not be available. Clinicians in New York State can contact the CEI line with clinical questions at 1-866-637-2342.

• Purpose of This Guideline
• PrEP for Individuals at Risk of Acquiring HIV
• Choosing and Prescribing a PrEP Regimen
• Laboratory Testing Before PrEP Initiation
• Ongoing Laboratory Testing
• Managing a Positive HIV Test Result
• Discontinuing PrEP
• Appendix: Care Provider Checklists for PrEP Initiation, Regimen Choice, and Follow-Up
• All Recommendations

• Purpose of This Guideline
• Considerations and Contraindications
• COVID-19
• Haemophilus influenzae Type B (Hib)
• Hepatitis A Virus (HAV)
• Hepatitis B Virus (HBV)
• Human Papillomavirus (HPV)
• Influenza
• Measles, Mumps, Rubella (MMR)
• Meningococcal Serotypes A, C, W, and Y (MenACWY)
• Meningococcal Serotype B (MenB)
• Mpox
• Pneumococcal
• Tetanus, Diphtheria, and Pertussis (Tdap) and Tetanus-Diphtheria (Td)
• Varicella
• Zoster
• All Recommendations

• Purpose of This Guideline
• Substance Use Screening and Risk Assessment: Goals and Definitions
• Screening
• Screening Tools
• Risk Assessment
• Patient Engagement and Interventions
• Diagnosis of Substance Use Disorder
• All Recommendations

• Purpose of This Guidance
• New York State Law and Federal Law
• Disclosure, Consent, and Confidentiality
• Good Practice Reminders and Resources

• Clinical Guidelines Program Approach to Shared Decision-Making
• PrEP Payment Options
• GOALS Framework for Sexual History Taking in Primary Care
• NYSDOH Health Equity Competencies for Health Care Providers
• Selected Links: Resources for Clinicians
• Selected Links: Resources for Consumers